MediWound (MDWD) EBIT Growth (3y) (2016 - 2025)

MediWound (MDWD) EBIT Growth (3y) (2016 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 16.96%
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 38.78%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 13.47%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -12.10%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 69.02%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 MediWound 183.16 Mn 178.36 Mn 278,000.00 -78.36%

Historic Data

Download Data
DateValue
Dec 31, 2025 -78.36%
Sep 30, 2025 -22.96%
Jun 30, 2025 -15.87%
Mar 31, 2025 -16.74%
Dec 31, 2024 -20.11%
Sep 30, 2024 -20.78%
Jun 30, 2024 -15.70%
Mar 31, 2024 -24.80%
Dec 31, 2023 -17.74%
Sep 30, 2023 -25.18%
Jun 30, 2023 -13.98%
Mar 31, 2023 -25.53%
Dec 31, 2022 38.82%
Sep 30, 2022 -8.84%
Jun 30, 2022 -31.30%
Mar 31, 2022 2.83%
Dec 31, 2021 -38.68%
Sep 30, 2021 -8.79%
Jun 30, 2021 4.13%
Mar 31, 2021 19.73%